Beijing Tiantan Hospital: Ischemic Stroke trials

The registry lists 81 Ischemic Stroke studies with Beijing Tiantan Hospital as lead sponsor. 40 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 2 16Phase 3 26Phase 4 2No phase 36(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Drug-Coated Balloon vs Aggressive Medical Management for High-Risk Symptomatic Intracranial Atherosclerotic StenosisNot yet recruitingNCT07830277Not applicable
• Direct Angio Suite Acute Stroke Intervention With CT/DSA Hybrid Emergency Stroke UnitNot yet recruitingNCT07670065Phase 3
• A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic StrokeNot yet recruitingNCT07645586Phase 3
• A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic StrokeNot yet recruitingNCT07645560Phase 2
• HBO After Thrombectomy for AIS With LVORecruitingNCT07626450Not applicable
• Prospective, Randomized, Parallel-Controlled Study of Brain Computer Interface Integrated Robotic Mirror Therapy for Post-Stroke Upper Limb Motor Function DisorderNot yet recruitingNCT07553416Not applicable
• Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous ThrombolysisRecruitingNCT07526987Phase 3
• Advancing Reperfusion Therapy for Ischemic Stroke: Direct Transfer to Angiography Suite for Patients With Suspected Large Vessel OcclusionNot yet recruitingNCT07460713Not applicable
• Emergency Stroke Unit With NeuAngio-CT (ESU-ACT)Not yet recruitingNCT07456228
• Advancing Reperfusion Therapy for Ischemic Stroke: Safety and Efficacy of Anakinra for Futile Reperfusion Following Endovascular Treatment in Patients With Acute Ischemic StrokeRecruitingNCT07423975Phase 2
• Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion StrokeRecruitingNCT07357987Phase 3
• INtensive liPid-lowering Therapy for Acute High-risk IntracRanial or Extracranial atheroSclerosis -II (INSPIRES-2)Not yet recruitingNCT07341958Not applicable
• Intravenous Tirofiban After Bridging Therapy for Acute Stroke With Atherosclerotic Large Artery OcclusionNot yet recruitingNCT07335107Phase 3
• The Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Due to Large Core InfarctionNot yet recruitingNCT07333950Not applicable
• Advancing Reperfusion Therapy for Ischemic Stroke: Perfusion-guided Endovascular Intervention for Medium Vessel Occlusion TherapyRecruitingNCT07323368Not applicable
• Observational RegIstry of Effectiveness and Safety of teNecTeplase in reAl worLd Settings in ChinaRecruitingNCT07271342
• Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT)Not yet recruitingNCT07252544Phase 3
• Ongericimab Injection Reducing Recurrence of Ischemic StrokeNot yet recruitingNCT07242599Phase 3
• Effect of the Intelligent Lipid Management Decision-support System on 1-year LDL-C Target Achievement in Ischemic Stroke or TIA Patients Under Evolocumab Treatment in ChinaRecruitingNCT07143149Not applicable
• Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic StrokeRecruitingNCT07047014Phase 3
• Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYONDRecruitingNCT06954155Phase 3
• Efficacy and Safety of Human Urinary Kallidinogenase for Acute Ischemic Stroke Patients Receiving Reperfusion TreatmentEnrolling by invitationNCT06848894Not applicable
• Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management SystemRecruitingNCT06783049Not applicable
• Effect of Acetaminophen on Neurological Outcome in Acute Ischemic Stroke Patients Undergoing Endovascular TreatmentNot yet recruitingNCT06767969Not applicable
• Safety and Preliminary Efficacy of NXL-001 in Patients With Ischemic StrokeRecruitingNCT06761183Early Phase 1
• Aleeto in Acute ISchemic Stroke：A RandomISed Controlled Clinical TrialRecruitingNCT06759753Phase 2
• The Androtriol Injection for the Treatment of Acute Ischemic StrokeNot yet recruitingNCT06679322Phase 2
• Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-D )RecruitingNCT06522282Phase 3
• Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4）RecruitingNCT06319846Phase 3
• GD-11 for Injection in the Treatment of Acute Ischemic StrokeRecruitingNCT06299579Phase 3
• Oxygen Concentration Target in Stroke Endovascular TreatmentRecruitingNCT06224426Not applicable
• Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)RecruitingNCT06157502Phase 3
• EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE)Not yet recruitingNCT06138834Phase 2
• A Registry Study of Microcirculation Disorder After Cerebral Small Vessel Disease and Ischemic StrokeNot yet recruitingNCT06077305
• Prognostic Prediction Model of Patients With AcUte Stroke undeRgoing EndOvascular TheRApy (AURORA)RecruitingNCT06009315
• Cilostazol Dexborneol Versus Placebo for Microcirculation Dysfunction After Reperfusion Therapy in Patients With Acute Ischemic Stroke With Large Vessel OcclusionRecruitingNCT05836766Phase 2
• Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion TherapyRecruitingNCT05836753Phase 2
• Cerebral Autoregulation Guiding Blood Pressure Management After RevascularizationNot yet recruitingNCT05670028Phase 2
• Intra-arterial Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy RecanalizationRecruitingNCT05624190Phase 4
• REperfusion Therapy for Acute Ischemic STrOke Due to Large aRtEry OcclusionRecruitingNCT05311605
• Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-C )CompletedNCT06522269Phase 3
• Y-3 for Injection in the Treatment of Acute Ischemic StrokeCompletedNCT06517173Phase 3
• Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-A )CompletedNCT06492239Phase 2
• Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical TrialCompletedNCT06429384Phase 2
• Lesion Network MApping Navigated Continuous Theta-burst STimulation for Motor REcovery in Acute Ischemic StrokeCompletedNCT06400407Phase 2
• The Improve Acute Reperfusion Treatment Quality for Ischemic Stroke Through Spatiotemporal Computing Thecnology in ChinaCompletedNCT06330051Not applicable
• Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic StrokeCompletedNCT06316570Phase 3
• Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery OcclusionCompletedNCT06221371Phase 3
• Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5CompletedNCT06196320Phase 3
• Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO)Active, not recruitingNCT06101667Not applicable
• Low-Frequency REpetitive TRanscranial Magnetic Stimulation Combined With Endovascular Treatment in ACute Ischemic StrokECompletedNCT06064747Not applicable
• Low-Frequency REpetitive TRanscranial Magnetic Stimulation in ACute Ischemic StrokE Within 48 HoursCompletedNCT06064734Not applicable
• Y-3 Injection Through Skull Bone Marrow in the Treatment of Acute Malignant Middle Cerebral Artery Infarction (SOLUTION)CompletedNCT05849805Not applicable
• Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic StrokeCompletedNCT05836740Phase 3
• Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）Status unknownNCT05745259Phase 3
• Tenecteplase REperfusion in Acute Ischemic sTroke Registry（TREAT）Status unknownNCT05724342
• Evaluating the Safety and Efficacy of the Maurora® DES in ICASCompletedNCT05719883Not applicable
• Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion TherapyStatus unknownNCT05700097Phase 2
• ProUrokinase for Mild Ischemic Cerebrovascular Events (PUMICE)CompletedNCT05507645Phase 3
• Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)CompletedNCT05439356Phase 3
• Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-II）Status unknownNCT05281549Phase 2
• Treatment of Acute Ischemic STroke With Edaravone Dexborneol II (TASTE-2)CompletedNCT05249920Phase 3
• Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-IIICompletedNCT05141305Phase 3
• Randomized Study of Bailout Intracranial Angioplasty Following Thrombectomy for Acute Large Vessel OcclusionCompletedNCT05122286Not applicable
• RECO in the Endovascular Treatment of Acute Ischemic StrokeStatus unknownNCT04840719
• Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-ⅡCompletedNCT04797013Phase 3
• Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE)CompletedNCT04676659Phase 2
• Study of Endovascular Therapy in Acute Anterior Circulation Large Vessel Occlusive Patients With a Large Infarct CoreCompletedNCT04551664Not applicable
• An AI-Based CDSS for Integrated Management of Patients With Acute Ischemic Stroke(GOLDEN BRIDGE II)Status unknownNCT04524624Not applicable
• Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of OnsetCompletedNCT04486430Phase 2
• The Effectiveness of Rehabilitation Training Based on Brain-computer Interface Technology to Improve the Upper Limb Motor Function of Ischemic Stroke.CompletedNCT04387474Not applicable
• The Trial of Ewata Balloon Guiding in the Application of ThrombectomyCompletedNCT04315844Not applicable
• Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic Stroke (ANGEL-ACT): Phase TwoStatus unknownNCT04151589Not applicable
• INdobufen Versus aSpirin in acUte Ischemic stRokE,INSURECompletedNCT03871517Phase 4
• Improve Acute Reperfusion Treatment Quality for Stroke in China, IMPROVE: Stroke Care in ChinaCompletedNCT03578107Not applicable
• Efficacy and Safety of Butylphthalide for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis or Endovascular TreatmentCompletedNCT03539445Phase 3
• Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic StrokeCompletedNCT03370939
• Choice of Anesthesia for Endovascular Treatment of Acute Ischemic Stroke in Posterior CirculationCompletedNCT03317535Not applicable
• Impact of Anesthesia Type on Outcome in Patients With Acute Ischemic Stroke (AIS) Undergoing Endovascular TreatmentStatus unknownNCT02677415Not applicable
• A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke.CompletedNCT02526225Phase 2
• Intervention to Bridge the Evidence-based Gap in Stroke Care QualityCompletedNCT02212912Not applicable